Previous Article | Next Article 
Journal of Clinical Microbiology, June 2000, p. 2374-2377, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Isolation of
Acanthamoeba-Specific Antibodies from a
Bacteriophage Display Library
Naveed A.
Khan,1
John
Greenman,2
Katherine P.
Topping,2
Victoria C.
Hough,2
Graham S.
Temple,3 and
Timothy
A.
Paget1,*
Department of Biological
Science,1 Academic Surgical
Unit,2 The University of Hull, and Public
Health Lab Hull Royal Infirmary,3 Hull, United
Kingdom HU6 7RX
Received 21 December 1998/Returned for modification 20 May
1999/Accepted 22 December 1999
 |
ABSTRACT |
Acanthamoeba causes opportunistic eye
infections in humans, which can lead to severe keratitis and may
ultimately result in blindness. Current methods for identifying this
organism rely on culture and microscopy. In this paper, we describe the
isolation of antibody fragments that can be used for the unequivocal
identification of Acanthamoeba. A
bacteriophage antibody display library was used to isolate antibody
fragments that bind specifically to
Acanthamoeba. Individual clones were studied by
enzyme-linked immunosorbent assay, flow cytometry, and
immunofluorescence. Four antibody clones that specifically bind to
Acanthamoeba spp. were identified.
 |
INTRODUCTION |
Acanthamoeba
is a free-living, opportunistic protozoan parasite of humans.
Acanthamoeba can cause a fatal
meningoencephalitis, but it is most commonly associated with eye
infections, typically, Acanthamoeba keratitis
associated with contact lens use. The increasing prevalence of this
keratitis is thought to be linked to the increased use of contact
lenses (8, 10, 15). Acanthamoeba
keratitis is usually diagnosed after viral and bacterial causes have
been eliminated (1, 5) and, as a result, there is often a
significant delay before appropriate treatment is administered. Because
of the severity of Acanthamoeba keratitis, a
significant loss of visual acuity is common and in many cases total
loss of sight in the infected eye occurs (4, 6). Current
methods of detection involve culture and microscopic identification
(9, 16). These methods are time consuming, laborious, and
open to error. The development of a rapid, simple detection method for
Acanthamoeba is thus important (2,
14).
Bacteriophage antibody display libraries expressing single-chain Fv
antibody fragments have recently been developed as an alternative way
of isolating specific antibodies (17). Antibody fragments
are generated by the random pairing of large diverse repertoires of
variable heavy and light chain genes, derived by PCR from activated or
naive human lymphocytes, and cloned for expression of individual
specificities on the surface of filamentous bacteriophages. A library
contains a vast number of different antibody specificities, varying
from 107 to 1012, depending on how the library
is constructed. This approach to generating antibodies has the major
advantage that epitopes do not have to be immunogenic, i.e., antibodies
that recognize native cell surface structures can be isolated. Here, we
describe the isolation of antibody fragments that can be used to detect
Acanthamoeba immunofluorescence and flow
cytometry. These antibodies provide the reagents to establish a
specific and rapid detection assay for
Acanthamoeba.
 |
MATERIALS AND METHODS |
Cell culture.
Pathogenic and nonpathogenic
Acanthamoeba species were obtained either from
the Culture Collection of Algae and Protozoa or from S. Kilvington
(Leicester PHL). Bacteria used in this study were obtained from Hull
PHL (Hull Royal Infirmary). All Acanthamoeba spp. and the Hartmanella sp. were maintained in PYG medium
(0.75% [wt/vol] proteose peptone, 0.75% [wt/vol] yeast extract
[Difco Laboratories, Detroit, Mich.] and 1.5% [wt/vol] glucose) at
30°C, and cultures reached mid-log phase after 7 days. Mid-log-phase cells were used for all experiments and were harvested by
centrifugation at 800 × g for 8 min. Cells were
resuspended in Page's amoeba saline (PAS) (13) and
centrifuged at 800 × g for 8 min; this was repeated
twice. Cells used for isolating antibody fragments, enzyme-linked
immunosorbent assay (ELISA), or fluorescence-activated cell sorter
analysis were fixed in 50% (vol/vol) methanol:PAS. After fixation,
cells were washed three times with PAS as described above. Organisms
used for immunofluorescence microscopy were harvested by centrifugation
and then placed onto slides prior to fixation.
Bacteriophage display library.
The human synthetic ScFv
library no. 1 (Nissim Library), a human-derived bacteriophage antibody
library expressing a single-chain Fv fragment was obtained from G. Winter (Centre for Protein Engineering, Medical Research Council
Centre, Cambridge, United Kingdom) (12). This library
consists of a single V
3 light chain paired with a bank of in
vitro-rearranged VH gene fragments containing a random VH CDR3 of 4 to 12 amino acid residues in length. This
library possesses more than 108 specificities.
Preparation of bacteriophage particles.
For bacteriophage
particle preparation, the library stock or individual bacteriophage
clones were added to a culture of Escherichia coli (TG1)
grown in 2× TY (0.8% [wt/vol] NaCl, 1.6% [wt/vol] tryptone, 0.5% [wt/vol] yeast extract) supplemented with 100 µg of
ampicillin per ml and 1% (wt/vol) glucose. This culture was incubated
at 37°C until the absorbance at 600 nm was between 0.4 and 0.5. VCS-M13 helper bacteriophage was then added to the culture, which was incubated for a further 30 min at 37°C without shaking. The culture was centrifuged at 1,500 × g for 10 min, the pellet
was resuspended in 2× TY supplemented with 100 µg of ampicillin per
ml and 25 µg of kanamycin per ml (to select for
bacteriophage-containing clones), and incubated at 30°C overnight.
The overnight culture was centrifuged at 10,800 × g
for 10 min and the pellet was resuspended in a 1/5 volume of 20%
(wt/vol) polyethylene glycol 6000 in 2.5 M NaCl for 1 h at 4°C.
After incubation and three washes, the pellet was resuspended in PAS
with 15% glycerol and centrifuged at 1,500 × g for 10 min. Finally, the supernatant containing the bacteriophage particles
was filtered (pore size, 0.45 µm) prior to storage at
80°C. The
bacteriophage particle titer was determined by serial dilution of
infected E. coli (TG1) plated out on TYE (1.5% [wt/vol]
Bacto-agar, 0.8% NaCl, 1% tryptone, and 5% yeast extract)
supplemented with 25 µg of kanamycin per ml.
Use of bacteriophage antibody display library.
To isolate
Acanthamoeba-specific antibody fragments the
bacteriophage library (2 × 1011 bacteriophages) was
added to a suspension of whole fixed cells (2 × 106
cells) which had been blocked by incubation in MPAS (2% [wt/vol] dried milk powder, 1% [wt/vol] bovine serum albumin in PAS) at 37°C for 1 h prior to use. The mixture of bacteriophage
particles and Acanthamoeba parasites was
incubated at 20°C with gentle shaking for 1 h and then
centrifuged at 200 × g for 5 min. The pellet was
resuspended in 0.1% (wt/vol) bovine serum albumin in PAS and centrifuged again; this process was repeated 10 times in total, to
remove unbound bacteriophage particles. The pellet was resuspended in
citric acid (76 mM) and incubated at 20°C with shaking to elute bound
bacteriophage particles. The pH of the mixture was then adjusted to 7.0 by adding Tris-HCl (1 M), pH 7.4. This procedure was termed a panning
round. The bacteriophage particles selected by this procedure were then
amplified as described previously (see "Preparation of bacteriophage
particles" above), except that bacteria infected with bacteriophage
were spread onto TYE bioassay dishes and incubated at 30°C overnight.
The E. coli (TG1) cells containing bacteriophage were
scraped from the plate and resuspended in 2× TY containing 15%
(wt/vol) glycerol and this suspension, termed the library stock, was
stored at
80°C.
To remove nonspecifically binding bacteriophage, a negative panning
round against the amoeba Hartmanella sp. was performed as
described for Acanthamoeba, except that the
supernatant containing unbound bacteriophage particles was retained.
Four further negative panning rounds were performed to ensure complete
removal of all cross-reactive bacteriophage particles. The supernatant
obtained from the final negative panning was then incubated with 2 × 106 fixed and blocked
Acanthamoeba cells. In summary, four panning rounds were performed in the following order: a positive pan against Acanthamoeba; a negative pan on
Hartmannella followed immediately by a positive pan on
Acanthamoeba; and, finally, two positive panning
rounds against Acanthamoeba.
PCR.
PCR for CDR3 length was performed to demonstrate the
diversity of bacteriophage clones isolated after each panning round
(11). Primers used were CDR-FOR (5' CAG GGT ACC TTG GCC CCA
3') and CDR-BACK (5' GTG TAT TAC TGT GCA AGA 3') (11). PCR
fragments amplified directly from bacterial colonies were
separated on 5% (wt/vol) Metaphor agarose gel (Flowgen, FMC
Bioproducts) stained with ethidium bromide and visualized under UV light.
ELISA.
Single bacterial colonies were picked directly from
the bioassay dish and inoculated into 2× TY supplemented with 100 µg
of ampicillin per ml and 1% (wt/vol) glucose and grown in 96-well round-bottom plates overnight at 37°C. Glycerol stocks of the overnight incubations were made by adding 15% (wt/vol) glycerol, and
they were stored at
80°C until required. To rescue the
bacteriophage, 5 µl of the glycerol stock culture was transferred
into 2× TY and incubated with shaking at 37°C for 1 h. VCS-M13
helper bacteriophage particles (1 × 109) were added
to each well and incubated at 37°C for 30 min without shaking and for
1 h with shaking. The culture was centrifuged at 400 × g for 10 min, and the supernatant was aspirated. The pellet was
resuspended in 2× TY supplemented with 100 µg of ampicillin per ml
plus 50 µg of kanamycin per ml and incubated overnight at 30°C with
shaking (bacteriophage plate). Fixed and MPAS-blocked Acanthamoeba parasites (2 × 105) were added to a conical 96-well plate and centrifuged
at 200 × g for 5 min. The supernatant was carefully
removed, and the wells were washed with PAS. Bacteriophage plates
incubated overnight were centrifuged at 400 × g for 10 min, and the supernatant was used as a source of the bacteriophage
clones. To each well of the plate containing immobilized
Acanthamoeba, individual bacteriophage clones
were added, and the plate was incubated with shaking at 20°C for
1 h and then washed with PAS. Sheep anti-M13-horseradish peroxidase (Pharmacia) (diluted 1:500 in MPAS) was added to each well,
and the plates were incubated with shaking at 20°C for 1 h.
Wells were washed twice with PAS before
2,2'-azinobis(3-ethylbenzthiazoline sulfonic acid) (ABTS) substrate
(Vector Laboratories) was added. The plate was then incubated at 20°C
for 30 min in the dark. The supernatant was transferred to a
flat-bottom plate and the absorbance (at 405 to 690 nm) was determined.
Flow cytometry.
Acanthamoeba
parasites (1 × 106) were fixed and blocked as
described above, mixed with 1 × 1012 bacteriophage
particles from the appropriate clone and incubated at 4°C for 1 h. Cells were washed three times with 0.25% (wt/vol) bovine serum
albumin in PAS (PAA). The final pellet was resuspended in sheep
anti-M13 antibody (10 µg/ml) and incubated at 4°C for 1 h.
Cells were washed twice with PAA, resuspended in fluorescein isothiocyanate-conjugated anti-sheep immunoglobulin G (IgG) (10 µg/ml; Vector Laboratories) and incubated at 4°C for 1 h.
Cells were washed twice as described above and finally resuspended in PAA and analyzed by flow cytometry. Fluorescence intensity was measured
on a FACSCalibur (Becton Dickinson), using an excitation wavelength of
488 nm.
 |
RESULTS |
ELISA.
Over 300 clones were analyzed by ELISA. The 10 clones
with the highest level of binding to Acanthamoeba
palestinensis (the absorbance at between 405 and 690 nm was >0.8)
were selected for further study. All these clones showed
cross-reactivity with all other Acanthamoeba
species studied (the absorbance at between 405 and 690 nm was between
0.8 and 1.1). PCR (Fig. 1) showed the diversity of the selected clones.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 1.
Diversity in insert sizes of different clones selected
from 96-well ELISA plate using CDR-FOR and CDR-BACK primers. Lane 1, 10-bp DNA ladder; lanes 2 to 26, PCR reaction products from 25 individual bacterial colonies selected at random from a TYE plate.
|
|
Flow cytometry.
Flow cytometry showed a high level of antibody
fragment binding to Acanthamoeba cells with no
binding to a range of other cell types (Table
1). Mean channel fluorescence for clone
HPPG6 with A. palestinensis was 200 as compared to 48 for
cells stained with the negative irrelevant bacteriophage (Fig. 2a).
When this was repeated for a Hartmanella sp. (Fig.
2b), no change in mean channel
fluorescence could be observed between the negative phage and HPPG6.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Flow cytometric analysis of clone HPPG6 against A. palestinensis (A) and Hartmanella sp. (B). Parasites
(1 × 106) were incubated with bacteriophage clone
HPPG6 or the irrelevant anti-NIP control (1 × 1012)
for 1 h at 4°C. Cells were then stained with a polyclonal sheep
anti-M13 and fluorescein isothiocyanate-conjugated donkey anti-sheep
IgG (10 µg/ml). Samples were analyzed on a FACSCalibur flow
cytometer.
|
|
Indirect immunofluorescence.
The selected antibody fragments
were also assessed by indirect immunofluorescence microscopy and
yielded results similar to those obtained by flow cytometry. Figure
3 shows A. palestinensis stained with HPPG6. It can be seen from the photomicrograph that this
antibody binds uniformly, with a high intensity, to all cells.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Under a light microscope. (B) Indirect
immunofluorescence reactivities of clone HPPG 6 with A. palestinensis. Magnification, ×400.
|
|
 |
DISCUSSION |
In this study we have shown that antibody fragments showing a high
level of specificity for Acanthamoeba spp. can
be isolated from a naive bacteriophage display library. This is the
first time that bacteriophage antibody display technology has been used in the development of an antibody for the identification of a microorganism. Previously, similar technology has been used
successfully to isolate a melanoma-specific antibody, but this work
required extensive screening of more than 1,700 clones before a useful reagent was identified (3). It is significant that we have been able to isolate four clones with the desired specificities from an
initial screen of only 300 clones. This suggests that bacteriophage
antibody display technology is ideally suited for the isolation of
novel antibodies for use as research and diagnostic tools in clinical microbiology.
Current methods for the rapid identification of
Acanthamoeba involve staining preparations with Giemsa,
calcofluor white, methylene blue, or acridine orange. Culturing is also
widely used in clinical laboratories for the reliable identification of
Acanthamoeba. However, accurate diagnosis and
interpretation of results using these techniques requires a strong
clinical suspicion of amoebic infection and highly trained personnel.
Other groups have utilized PCR as a rapid detection method for
Acanthamoeba (14), but the specificity and sensitivity of this technique in a clinical environment have not been tested. Rabbit polyclonal antisera have also been used
for the detection of Acanthamoeba keratitis and
suspected Acanthamoeba meningoencephalitis.
However, these reagents showed considerable cross-reactivity with other
cell types, and, once again, the sensitivity of the assay has been
questioned (7).
The need for a simple and rapid method for the specific detection of
Acanthamoeba has become more urgent as
Acanthamoeba keratitis becomes a more
significant causative agent of eye keratitis due to greater contact
lens use and is increasingly associated with meningoencephalitis in
immunocompromised individuals. We believe that the clones isolated in
this study will form the basis of a rapid and unequivocal assay for the
detection of Acanthamoeba. Thus, bacteriophage
antibody display libraries are potentially useful and powerful tools
that allow the rapid generation of antibody reagents for use in
diagnostic assays.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biological Sciences, Hardy Building, Cottingham Rd., The University of Hull, Hull HU6 7RX, United Kingdom. Phone: 44-1482-465506. Fax: 44-1482-465458. E-mail:
T.A.Paget{at}biosci.hull.ac.uk.
 |
REFERENCES |
| 1.
|
Aitken, D.,
J. Hay,
M. C. Kinnear, and R. C. Lee.
1996.
Amebic keratitis in a wearer of disposable contact lenses due to a mixed Vahlkampfia and Hartmannella infection.
Opthalmology
103:485-494[Medline].
|
| 2.
|
Bacon, S. A.,
K. G. John,
A. L. Ficker,
M. M. Matheson, and P. Wright.
1993.
Acanthamoeba keratitis: the value of early diagnosis.
Opthalmology
100:1238-1243[Medline].
|
| 3.
|
Cai, X., and A. Garen.
1995.
Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumour cells: Selection of specific antibodies from single-chain Fv fusion phage libraries.
Proc. Natl. Acad. Sci. USA
92:6537-6541[Abstract/Free Full Text].
|
| 4.
|
Chynn, W. E.,
A. M. Lopez,
P. D. Langston, and H. J. Talamo.
1995.
Acanthamoeba keratitis.
Opthalmology
102:1369-1373[Medline].
|
| 5.
|
Cohen, J. E.,
W. H. Buchanan,
A. P. Laughrea,
P. C. Adams,
G. P. Galentine,
P. Folberg,
J. J. Arentsen, and R. P. Laibson.
1985.
Diagnosis and management of Acanthamoeba keratitis.
Am. J. Opthalmol.
100:389-395[Medline].
|
| 6.
|
Cohen, J. E.,
C. J. Fultan,
J. C. Hoffman,
J. C. Rapuano, and R. P. Laibson.
1996.
Trends in contact lens-associated corneal ulcers.
Cornea
15:566-570[Medline].
|
| 7.
|
Flores, B. M.,
C. A. Garcia,
W. E. Stamm, and B. E. Torian.
1990.
Differentiation of Naegleria fowleri from Acanthamoeba species by using monoclonal antibodies and flow cytometry.
J. Clin. Micro.
28:1999-2005[Abstract/Free Full Text].
|
| 8.
|
Grey, B. T.,
T. M. Ray,
F. Sherwan, and R. P. Rose.
1995.
Acanthamoeba, bacterial and fungal contamination of contact lens storage cases.
Br. J. Opthalmol.
79:601-605[Abstract/Free Full Text].
|
| 9.
|
John, J. K.,
W. Steven,
M. C. Parrish,
E. T. Williams,
D. R. Robinson, and M. Denis.
1989.
Examination of hydrophilic contact lenses with light microscopy to aid in the diagnosis of Acanthamoeba keratitis.
Am. J. Opthalmol.
108:329-331[Medline].
|
| 10.
|
Ma, P.,
G. S. Visvesvara,
A. J. Martinez,
F. H. Theodore,
P. M. Daggett, and T. K. Sawyer.
1991.
Naegleria and Acanthamoeba infections.
Rev. Infect. Dis.
13(Suppl. 5):369-372.
|
| 11.
|
Marks, J. D.,
H. R. Hoogenboom,
T. P. Bonnert,
A. D. McCafferty,
A. Griffiths, and G. Winter.
1991.
Human antibodies from bacteriophage display libraries.
J. Mol. Biol.
222:581[CrossRef][Medline].
|
| 12.
|
Nissim, A.,
R. H. Hoogenboom,
M. I. Tomlinson,
G. Flynn,
C. Midgley,
D. Lane, and G. Winter.
1994.
Antibody fragments from a `single pot' phage display library as immunochemical reagents.
EMBO J.
13:692-698[Medline].
|
| 13.
|
Page, F. C.
1988.
A new key to the fresh water and soil Gymnamoebae with instructions for culture.
Freshwater Biological Association, Ferry House, Ambleside, Cumbria, United Kingdom.
|
| 14.
|
Vodkin, M. H.,
K. D. Howe,
S. G. Visvesvara, and L. G. Mclaughlin.
1992.
Identification of Acanthamoeba at the generic and specific levels using the polymerase chain reaction.
J. Protozool.
39:378-385[Medline].
|
| 15.
|
Wilhelmus, K. R.
1991.
The increasing importance of Acanthamoeba.
Rev. Infect. Dis.
13(Suppl. 5):367-446.
|
| 16.
|
Winchester, K.,
D. W. Mathers,
E. J. Sutphin, and E. T. Daley.
1995.
Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy.
Cornea
14:10-17[Medline].
|
| 17.
|
Winter, G.,
D. A. Griffiths,
E. R. Hawkins, and R. H. Hoogenboom.
1994.
Making antibodies by phage display technology.
Annu. Rev. Immunol.
12:433-456[Medline].
|
Journal of Clinical Microbiology, June 2000, p. 2374-2377, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Smith, K A, Nelson, P N, Warren, P, Astley, S J, Murray, P G, Greenman, J
(2004). Demystified...recombinant antibodies.. J. Clin. Pathol.
57: 912-917
[Abstract]
[Full Text]
-
Marciano-Cabral, F., Cabral, G.
(2003). Acanthamoeba spp. as Agents of Disease in Humans. Clin. Microbiol. Rev.
16: 273-307
[Abstract]
[Full Text]